Fisher Funds Management LTD Takes $86.68 Million Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Fisher Funds Management LTD purchased a new position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 166,158 shares of the medical equipment provider’s stock, valued at approximately $86,676,000. Intuitive Surgical comprises 2.1% of Fisher Funds Management LTD’s holdings, making the stock its 15th biggest holding.

Other institutional investors also recently added to or reduced their stakes in the company. Pinnacle Financial Partners Inc grew its position in shares of Intuitive Surgical by 3.7% during the fourth quarter. Pinnacle Financial Partners Inc now owns 23,329 shares of the medical equipment provider’s stock worth $12,177,000 after acquiring an additional 837 shares during the last quarter. Bradley Foster & Sargent Inc. CT raised its position in Intuitive Surgical by 1.7% in the 4th quarter. Bradley Foster & Sargent Inc. CT now owns 41,908 shares of the medical equipment provider’s stock valued at $21,874,000 after purchasing an additional 719 shares during the last quarter. Compass Capital Corp MA ADV acquired a new stake in Intuitive Surgical during the 4th quarter worth $506,000. Centricity Wealth Management LLC purchased a new position in Intuitive Surgical during the 4th quarter worth $47,000. Finally, Tandem Investment Advisors Inc. increased its stake in Intuitive Surgical by 1.9% in the fourth quarter. Tandem Investment Advisors Inc. now owns 9,954 shares of the medical equipment provider’s stock valued at $5,196,000 after purchasing an additional 182 shares during the period. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insiders Place Their Bets

In other Intuitive Surgical news, EVP Myriam Curet sold 408 shares of Intuitive Surgical stock in a transaction dated Tuesday, February 11th. The shares were sold at an average price of $589.75, for a total transaction of $240,618.00. Following the completion of the transaction, the executive vice president now owns 353 shares in the company, valued at approximately $208,181.75. The trade was a 53.61 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CFO Jamie Samath sold 269 shares of the stock in a transaction that occurred on Monday, February 10th. The shares were sold at an average price of $590.00, for a total transaction of $158,710.00. Following the completion of the sale, the chief financial officer now owns 3,282 shares in the company, valued at $1,936,380. This represents a 7.58 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 6,348 shares of company stock worth $3,587,582. 0.90% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on the stock. Jefferies Financial Group increased their target price on shares of Intuitive Surgical from $475.00 to $575.00 in a research note on Monday, January 27th. Morgan Stanley raised Intuitive Surgical from an “equal weight” rating to an “overweight” rating and increased their price objective for the stock from $522.00 to $650.00 in a research report on Monday, December 2nd. Evercore ISI lifted their target price on Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. Barclays upped their price target on Intuitive Surgical from $610.00 to $674.00 in a research note on Monday, January 27th. Finally, Truist Financial lifted their price objective on shares of Intuitive Surgical from $640.00 to $666.00 and gave the company a “buy” rating in a research report on Friday, January 24th. One analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $613.10.

Intuitive Surgical Price Performance

ISRG opened at $591.79 on Friday. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00. The stock has a market cap of $210.78 billion, a P/E ratio of 92.32, a P/E/G ratio of 5.85 and a beta of 1.39. The stock’s 50 day simple moving average is $565.45 and its 200 day simple moving average is $525.06.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.